Emerging roles of ILC2s in antitumor immunity.
作者信息
Li Zhao, Sun Hanxiao, Gu Zhitao, Qiu Ju
机构信息
CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
Department of Blood Transfusion, Shanghai Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China.
出版信息
Cell Mol Immunol. 2022 Nov;19(11):1311-1313. doi: 10.1038/s41423-022-00918-6. Epub 2022 Sep 2.
Abstract
摘要
相似文献
1
Emerging roles of ILC2s in antitumor immunity.2型固有淋巴细胞在抗肿瘤免疫中的新作用。
Cell Mol Immunol. 2022 Nov;19(11):1311-1313. doi: 10.1038/s41423-022-00918-6. Epub 2022 Sep 2.
2
Group 2 innate lymphoid cells boost CD8 T-cell activation in anti-tumor immune responses.2 型固有淋巴细胞促进抗肿瘤免疫应答中 CD8 T 细胞的激活。
Oncoimmunology. 2023 Aug 9;12(1):2243112. doi: 10.1080/2162402X.2023.2243112. eCollection 2023.
3
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for mutation-driven intestinal tumorigenesis.先天 IL-25-ILC2-MDSC 轴为驱动突变的肠道肿瘤发生创造了有利于癌症的微环境。
Sci Immunol. 2022 Jun 3;7(72):eabn0175. doi: 10.1126/sciimmunol.abn0175.
4
Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.肺脏 2 组固有淋巴细胞依赖局部 IL-7 来实现其在固有免疫和适应性免疫介导的气道炎症中的分布、激活和维持的差异。
Int Immunol. 2023 Nov 7;35(11):513-530. doi: 10.1093/intimm/dxad029.
5
Systemic administration of IL-33 induces a population of circulating KLRG1 type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma.系统性给予白细胞介素-33 可诱导循环中 KLRG1 型 2 型固有淋巴细胞的产生，并抑制针对多发性骨髓瘤的 1 型固有免疫。
Immunol Cell Biol. 2021 Jan;99(1):65-83. doi: 10.1111/imcb.12390. Epub 2020 Sep 18.
6
Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity.白细胞介素-33 诱导色氨酸羟化酶 1 促进炎症性 2 型固有淋巴细胞介导的免疫。
Immunity. 2020 Apr 14;52(4):606-619.e6. doi: 10.1016/j.immuni.2020.02.009. Epub 2020 Mar 10.
7
The Skinny: Pancreatic ILC2s Promote Insulin Secretion.要点：胰腺 ILC2s 促进胰岛素分泌。
Immunity. 2017 Nov 21;47(5):812-814. doi: 10.1016/j.immuni.2017.11.004.
8
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.ILC2s 通过激活组织特异性癌症免疫来增强 PD-1 阻断作用。
Nature. 2020 Mar;579(7797):130-135. doi: 10.1038/s41586-020-2015-4. Epub 2020 Feb 19.
9
Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases.2 型固有淋巴细胞的异质性决定了它们在癌症、肥胖和心血管疾病中的多功能作用。
Front Immunol. 2022 Jun 29;13:939378. doi: 10.3389/fimmu.2022.939378. eCollection 2022.
10
Role of type 2 innate lymphoid cell and its related cytokines in tumor immunity.2 型固有淋巴细胞及其相关细胞因子在肿瘤免疫中的作用。
J Cell Physiol. 2020 Apr;235(4):3249-3257. doi: 10.1002/jcp.29287. Epub 2019 Oct 17.
本文引用的文献
1
An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for mutation-driven intestinal tumorigenesis.先天 IL-25-ILC2-MDSC 轴为驱动突变的肠道肿瘤发生创造了有利于癌症的微环境。
Sci Immunol. 2022 Jun 3;7(72):eabn0175. doi: 10.1126/sciimmunol.abn0175.
2
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.真菌微生物组驱动胰腺癌中的 IL-33 分泌和 2 型免疫。
Cancer Cell. 2022 Feb 14;40(2):153-167.e11. doi: 10.1016/j.ccell.2022.01.003. Epub 2022 Feb 3.
3
Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression.单细胞转录组图谱揭示与结直肠癌进展相关的肿瘤特异性固有淋巴细胞。
Cell Rep Med. 2021 Jul 27;2(8):100353. doi: 10.1016/j.xcrm.2021.100353. eCollection 2021 Aug 17.
4
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.PD-1 影响人类非小细胞肺癌中 2 类固有淋巴细胞的免疫抑制功能。
Front Immunol. 2021 Jun 14;12:680055. doi: 10.3389/fimmu.2021.680055. eCollection 2021.
5
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.阻断共抑制分子 PD-1 可释放 ILC2 依赖性抗肿瘤免疫应答于黑色素瘤。
Nat Immunol. 2021 Jul;22(7):851-864. doi: 10.1038/s41590-021-00943-z. Epub 2021 Jun 7.
6
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.PPARɣ 驱动 IL-33 依赖的 ILC2 促肿瘤功能。
Nat Commun. 2021 May 5;12(1):2538. doi: 10.1038/s41467-021-22764-2.
7
Type 2 Innate Lymphoid Cells Protect against Colorectal Cancer Progression and Predict Improved Patient Survival.2型固有淋巴细胞可预防结直肠癌进展并预示患者生存率提高。
Cancers (Basel). 2021 Feb 1;13(3):559. doi: 10.3390/cancers13030559.
8
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung.ILC2 驱动的固有免疫检查点机制拮抗 NK 细胞在肺部的抗转移功能。
Nat Immunol. 2020 Sep;21(9):998-1009. doi: 10.1038/s41590-020-0745-y. Epub 2020 Aug 3.
9
Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.结直肠癌进展过程中肿瘤浸润固有淋巴细胞的转分化。
Cell Res. 2020 Jul;30(7):610-622. doi: 10.1038/s41422-020-0312-y. Epub 2020 May 4.
10
Mesenchymal PGD activates an ILC2-Treg axis to promote proliferation of normal and malignant HSPCs.间充质 PGD 通过激活 ILC2-Treg 轴促进正常和恶性 HSPC 的增殖。
Leukemia. 2020 Nov;34(11):3028-3041. doi: 10.1038/s41375-020-0843-8. Epub 2020 May 4.
Zotero 插件